A Phase 2 Study of OSI-906 in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors
Phase of Trial: Phase II
Latest Information Update: 24 Jan 2017
At a glance
- Drugs Linsitinib (Primary)
- Indications Gastrointestinal stromal tumours
- Focus Biomarker; Pharmacogenomic; Therapeutic Use
- 10 Feb 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 09 Jul 2013 Status changed from suspended to recruiting as reported by ClinicalTrials.gov.
- 08 May 2013 Status changed from recruiting to suspended as reported by ClinicalTrials.gov.